UBS analyst Mauricio Serna raised the firm’s price target on Dillard’s (DDS) to $460 from $184 and keeps a Sell rating on the shares. The firm updated the company’s model post the Q3 report. Dillard’s “is adept to drive modest sales growth,” the analyst tells investors in a research note. However, UBS sees “very limited” earnings growth potential for Dillard’s given its low-single-digit sales growth and flattish margins.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DDS:
